STOCK TITAN

Nasdaq Inc Stock Price, News & Analysis

NDAQ Nasdaq

Welcome to our dedicated page for Nasdaq news (Ticker: NDAQ), a resource for investors and traders seeking the latest updates and insights on Nasdaq stock.

Nasdaq Inc (NDAQ) drives innovation in global capital markets through its electronic trading platforms, market data services, and regulatory technology solutions. This dedicated news hub provides investors and professionals with direct access to official corporate announcements and market-moving developments.

Our curated collection simplifies tracking Nasdaq's strategic initiatives across its core business segments. Users will find timely updates on quarterly earnings, technology partnerships, regulatory compliance solutions, and market infrastructure enhancements. Each release maintains the original corporate messaging for accuracy.

Bookmark this page to monitor Nasdaq's evolving role in financial technology ecosystems, from AI-driven analytics to sustainable investing infrastructure. The resource serves as a primary channel for understanding how Nasdaq's innovations impact market transparency and operational efficiency worldwide.

News
Rhea-AI Summary

Nasdaq (NDAQ) announced its monthly trading volumes for May 2020, providing details on trading activity during the month. This information can be accessed through their investor relations website. The report highlights Nasdaq's ongoing efforts to keep stakeholders informed about trading metrics and market activities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
-
Rhea-AI Summary

The Nasdaq Stock Market (NDAQ) has announced that trading in CNS Pharmaceuticals Inc. (CNSP) will resume on May 28, 2020, at 7:00 a.m. Eastern Time. This follows a trading halt initiated on May 4, 2020, at 9:25:06 Eastern Time. The resumption of trading is significant for investors and reflects the ongoing activities of CNS Pharmaceuticals. For more details, stakeholders can look under the company's symbol on the Nasdaq website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
none
-
Rhea-AI Summary

The Nasdaq Stock Market (Nasdaq: NDAQ) has announced that trading of Moleculin Biotech, Inc. (Nasdaq: MBRX) will resume on May 28, 2020, at 7:00 a.m. Eastern Time. The trading was halted on May 4, 2020, at 9:25:06 a.m. Eastern Time. This resumption signifies the end of the trading disruption for MBRX stocks, allowing investors to re-engage with the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
none
Rhea-AI Summary

On May 26, 2020, Nasdaq CEO Adena Friedman announced her participation in two upcoming events. The first, Bernstein’s 36th Annual Strategic Decisions Conference, will take place on May 28, 2020, at 10:00 AM ET. The second event is the Piper Sandler Global Exchange & FinTech Conference, scheduled for June 4, 2020, also at 10:00 AM ET. Both presentations will be available via webcast on Nasdaq's Investor Relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
conferences
-
Rhea-AI Summary

Nasdaq announced that trading in Luckin Coffee Inc. (NDAQ: LK) will resume on May 20, 2020, at 7:00 a.m. Eastern Time. The stock was halted on April 7, 2020, at 9:15:25 Eastern Time due to regulatory issues. This resumption follows the company's efforts to address compliance matters. For further details, investors can access information under the company’s symbol using InfoQuotes on the Nasdaq website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.85%
Tags
none
-
News
Rhea-AI Summary

The Nasdaq Stock Market (NDAQ) announced that the trading halt on CNS Pharmaceuticals Inc. (CNSP) has been switched to an "additional information requested" status. This trading halt began on May 4, 2020, at 9:25:06 Eastern Time, with a last sale price of $2.76. Trading will remain suspended until CNS Pharmaceuticals Inc. provides the required information to Nasdaq.

For further updates, stakeholders are advised to check the Nasdaq website or directly contact the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.55%
Tags
none
News
Rhea-AI Summary

The Nasdaq Stock Market (NDAQ) announced on May 18, 2020, that trading in Moleculin Biotech Inc. (MBRX) has been halted since May 4, due to a request for additional information from the company. The last sale price before the halt was $1.07. Trading will remain suspended until Moleculin Biotech provides the required information to Nasdaq.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.55%
Tags
none
-
News
Rhea-AI Summary

The Nasdaq Stock Market (NDAQ) has revised the trading halt status for SCWorx Corp. (WORX) to "additional information requested" as of May 6, 2020. The company's stock was initially halted on April 22, 2020, at a price of $5.755. Trading will remain suspended until SCWorx Corp. provides the necessary information to Nasdaq.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.94%
Tags
none
-
News
Rhea-AI Summary

In April 2020, Nasdaq (NDAQ) published its monthly trading volumes on the investor relations website. The data sheet detailing these volumes and quarterly capture rates can be accessed online. Nasdaq is a global technology company that provides a variety of data, analytics, software, and services aimed at enhancing client business strategies. The release also includes a cautionary note highlighting risks and uncertainties, particularly regarding the impact of the COVID-19 pandemic on business performance and future projections.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.54%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
none

FAQ

What is the current stock price of Nasdaq (NDAQ)?

The current stock price of Nasdaq (NDAQ) is $81.06 as of May 14, 2025.

What is the market cap of Nasdaq (NDAQ)?

The market cap of Nasdaq (NDAQ) is approximately 44.8B.
Nasdaq Inc

Nasdaq:NDAQ

NDAQ Rankings

NDAQ Stock Data

44.83B
428.59M
10.72%
85.74%
0.84%
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
Link
United States
NEW YORK